Catch-up measles shots are not a side note while national cases near 4,000. Medscape reports a University of Maryland modeling study in the Proceedings of the National Academy of Sciences finding Florida’s MMR coverage — about 91.6% for children and 92.5% for adults in the paper’s estimates — already below the roughly 93%–94% herd-immunity threshold. Lead author Alice Oveson compared susceptible adults to dry kindling: one imported spark could ignite a large fire. The model warns that if school MMR requirements were dropped and childhood coverage fell toward worst-case levels near 82%, a pronounced outbreak could emerge within three to five years.

Florida pediatricians told Medscape they already see more families delaying or refusing MMR, even as other parents ask for early doses for infants 6 through 11 months when travel or outbreak risk rises. That early dose does not replace the routine two-dose series. CDC-aligned guidance still centers on two doses for lasting protection and post-exposure MMR within 72 hours for eligible people, or immune globulin within six days for those who cannot take live vaccine.

CIDRAP and Contagion Live’s national tallies underscore the same pattern: about 95% of 2026 U.S. cases involve unvaccinated people or unknown status, and Pennsylvania’s hot spot reports more than 99% unvaccinated or undervaccinated patients. Schools, churches, and workplaces remain common exposure settings when someone is infectious before the rash appears. Immunocompromised patients who cannot receive live MMR depend on high coverage around them.

Backstory: a 2025 Florida proposal to eliminate school MMR requirements did not pass, but state pediatric leaders told Medscape they expect similar bills to return when lawmakers reconvene in 2027. Overnight sticks to published modeling and outbreak reporting rather than predicting legislative votes.

What we know:
Florida MMR coverage is modeled below herd-immunity levels; two-dose MMR remains ~97% effective; national cases remain concentrated among the unvaccinated.

What we don’t:
How many eligible adults and children will complete catch-up shots before the next school holiday travel peak.